First personalised chemotherapy management assay
Olympus and Saladax Biomedical enter development agreement to accelerate a blood test expected to help oncologists more effectively dose 5-fluorouracil (5-FU), a widely used chemotherapy agent
The 5-FU test will enable more timely and cost-effective dosing, thereby optimising therapeutic effects and minimising toxicity among the 1.5 million patients treated annually around the world.
Pursuant to this agreement, SBI will adapt the first of a line of personalised chemotherapy management (PCM) assays for quantifying the concentration of 5-FU (Rubex/Efudex/Adrucil) in cancer patients to the Olympus AU400 clinical chemistry system, while the parties finalise the terms of the non-exclusive multi-year distribution agreement.
5-FU is indicated primarily for colorectal, gastrointestinal, breast and head and neck cancers.
In addition to the typically associated toxic side-effects of 5-FU such as soreness of the mouth, difficulty swallowing, diarrhoea, stomach pain, neutropenia and neuropathy, some patients face life threatening consequences from 5-FU treatment.
Three to five percent of the population have an enzyme deficiency (DPD deficiency) that is crucial for the metabolism and deactivation of 5-FU.
Such patients suffer from severe side effects, even death, with smallest doses and often with the very first dose of 5-FU.
"There is a large body of published clinical evidence that managing 5-FU dosing by measuring blood concentration has a significant positive impact on response to therapy and reduction of toxic side-effects.
"However, today doctors have no clinical relevant tool by which to get this information.
"Saladax plans to launch a simple 5-FU test within the year and we are pleased by the prospect of having it offered by a highly respected and quality partner such as Olympus," said Salvatore Salamone, chairman and chief executive officer of Saladax.
Not what you're looking for? Search the site.
Tel +49 40 23773-0
-
Olympus Life Science introduces Cell TIRF system
Olympus has introduced the Cell TIRF system as part of its Xcellence live cell fluorescence imaging station. -
Cellfrap delivers photo control experiments
Olympus has introduced the advanced Cellfrap system as part of its Xcellence live cell fluorescence imaging station. -
Olympus microscopes cover live-cell techniques
Olympus has introduced the Xcellence range of research microscope systems. -
Dotslide uses microscopy to generate virtual slide
Olympus has introduced an improved version of its Dotslide virtual slide system. -
MPLAPON objectives provide brightfield imaging
Olympus has introduced the MPLAPON series of plan apochromatic objectives, which provide chromatic aberration correction for materials imaging.
Browse by category
- Analytical instruments (9820)
- Chemical analysis equipment (733)
- Chromatographs: gas (252)
- Chromatographs: liquid, ion, gel, HPLC (471)
- Chromatography accessories (567)
- Gas analysis equipment (235)
- pH and conductivity meters (113)
- Cameras and imaging systems (907)
- Electron microscopy systems (243)
- Optical microscopes (499)
- Microscope supplies and accessories (612)
- Mass spectrometers (491)
- Spectroscopy (613)
- Other analytical instruments (631)
- Particle size analysis equipment (661)
- Microplate readers (45)
- Temperature, pressure and flow measurement (271)
- Spectrophotometers (299)
- Titration equipment (840)
- Ultrasound equipment and ultrasonic spectroscopy (118)
- Viscometers and rheometers (369)
- Oscilloscopes (85)
- Mechanical testing equipment (514)
- Test and calibration instrumentation (225)
- Life sciences and clinical laboratory equipment (4019)
- Computer hardware (854)
- Industry news (20)
- Laboratory equipment and wares (6559)
- Laboratory supplies and consumables (1394)
- Pumps, Valves, Filters (760)
- Services (3291)
- Computer software (3076)
